87 results
Page 2 of 5
8-K
EX-99.1
m9gc4tfemek4eve14
13 Aug 21
Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a
8:03am
8-K/A
9hb10667hkwl ry
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
D
fybtjns0zuh9o18a
30 Mar 21
$45.45M in equity / options / securities to be acquired, sold $45.45M, 26 investors
7:48am
8-K/A
EX-99.1
3lmcmym8mx x6
19 Mar 21
Financial Statements and Exhibits
8:51am
8-K
EX-3.1
1tcq9tu
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
8-K
EX-10.1
t1manm5y5
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
424B3
b327nx0zz x1
12 Feb 21
Prospectus supplement
12:05pm